FDAsafety guidance65% confidence
FDA AP — TRAMADOL HYDROCHLORIDE (SUPPL)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Teva.
Regulatory Analysis
Application ANDA075977. Sponsor: TEVA. Submission status: AP. Submission type: SUPPL. Active ingredients: TRAMADOL HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Diabetes · SGLT2 Inhibitor
- Sub-indication
- General
Related signal: Teva's ANDA Submission for Canagliflozin Receives TA Status